368 related articles for article (PubMed ID: 25890083)
1. Regulatory T cell-deficient scurfy mice develop systemic autoimmune features resembling lupus-like disease.
Hadaschik EN; Wei X; Leiss H; Heckmann B; Niederreiter B; Steiner G; Ulrich W; Enk AH; Smolen JS; Stummvoll GH
Arthritis Res Ther; 2015 Feb; 17(1):35. PubMed ID: 25890083
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T cell deficient scurfy mice exhibit a Th2/M2-like inflammatory response in the skin.
Haeberle S; Raker V; Haub J; Kim YO; Weng SY; Yilmaz OK; Enk A; Steinbrink K; Schuppan D; Hadaschik EN
J Dermatol Sci; 2017 Sep; 87(3):285-291. PubMed ID: 28811075
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T-cell deficiency leads to features of autoimmune liver disease overlap syndrome in scurfy mice.
Yilmaz K; Haeberle S; Kim YO; Fritzler MJ; Weng SY; Goeppert B; Raker VK; Steinbrink K; Schuppan D; Enk A; Hadaschik EN
Front Immunol; 2023; 14():1253649. PubMed ID: 37818371
[TBL] [Abstract][Full Text] [Related]
4. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
[TBL] [Abstract][Full Text] [Related]
5. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
Xiao ZY; Chen SH; Cheng JP; Zhou WX; Zhang YX; Yang RF; Yun LH
Arthritis Res Ther; 2012 Nov; 14(6):R235. PubMed ID: 23116248
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease.
Haeberle S; Wei X; Bieber K; Goletz S; Ludwig RJ; Schmidt E; Enk AH; Hadaschik EN
J Allergy Clin Immunol; 2018 Dec; 142(6):1831-1842.e7. PubMed ID: 29704595
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects.
Muramatsu K; Ujiie H; Kobayashi I; Nishie W; Izumi K; Ito T; Yoshimoto N; Natsuga K; Iwata H; Shimizu H
J Allergy Clin Immunol; 2018 Dec; 142(6):1818-1830.e6. PubMed ID: 29704593
[TBL] [Abstract][Full Text] [Related]
8. Scurfy Mice Develop Features of Connective Tissue Disease Overlap Syndrome and Mixed Connective Tissue Disease in the Absence of Regulatory T Cells.
Yilmaz OK; Haeberle S; Zhang M; Fritzler MJ; Enk AH; Hadaschik EN
Front Immunol; 2019; 10():881. PubMed ID: 31068947
[TBL] [Abstract][Full Text] [Related]
9. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH
Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
[TBL] [Abstract][Full Text] [Related]
10. A combination of cyclophosphamide and interleukin-2 allows CD4+ T cells converted to Tregs to control scurfy syndrome.
Delville M; Bellier F; Leon J; Klifa R; Lizot S; Vinçon H; Sobrino S; Thouenon R; Marchal A; Garrigue A; Olivré J; Charbonnier S; Lagresle-Peyrou C; Amendola M; Schambach A; Gross D; Lamarthée B; Benoist C; Zuber J; André I; Cavazzana M; Six E
Blood; 2021 Apr; 137(17):2326-2336. PubMed ID: 33545713
[TBL] [Abstract][Full Text] [Related]
11. Large functional repertoire of regulatory T-cell suppressible autoimmune T cells in scurfy mice.
Sharma R; Jarjour WN; Zheng L; Gaskin F; Fu SM; Ju ST
J Autoimmun; 2007 Aug; 29(1):10-9. PubMed ID: 17521882
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies in scurfy mice and IPEX patients recognize keratin 14.
Huter EN; Natarajan K; Torgerson TR; Glass DD; Shevach EM
J Invest Dermatol; 2010 May; 130(5):1391-9. PubMed ID: 20147963
[TBL] [Abstract][Full Text] [Related]
13. γδ T Cells Protect the Liver and Lungs of Mice from Autoimmunity Induced by Scurfy Lymphocytes.
Ujiie H; Shevach EM
J Immunol; 2016 Feb; 196(4):1517-28. PubMed ID: 26773142
[TBL] [Abstract][Full Text] [Related]
14. Impact of CD4+CD25high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus.
Atfy M; Amr GE; Elnaggar AM; Labib HA; Esh A; Elokely AM
Egypt J Immunol; 2009; 16(1):117-26. PubMed ID: 20726328
[TBL] [Abstract][Full Text] [Related]
15. Assessment of 1,25-dihydroxyvitamin D3 effects on Treg cells in a mouse model of systemic lupus erythematosus.
Lavi Arab F; Rastin M; Faraji F; Zamani Taghizadeh Rabe S; Tabasi N; Khazaee M; Haghmorad D; Mahmoudi M
Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):12-8. PubMed ID: 25318538
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of T-regulatory cells exaggerates angiotensin II-induced microvascular injury by enhancing immune responses.
Mian MO; Barhoumi T; Briet M; Paradis P; Schiffrin EL
J Hypertens; 2016 Jan; 34(1):97-108. PubMed ID: 26630215
[TBL] [Abstract][Full Text] [Related]
17. The role of CD4CD25 T cells in autoantibody production in murine lupus.
Hsu WT; Suen JL; Chiang BL
Clin Exp Immunol; 2006 Sep; 145(3):513-9. PubMed ID: 16907921
[TBL] [Abstract][Full Text] [Related]
18. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
Hahn BH; Anderson M; Le E; La Cava A
Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553
[TBL] [Abstract][Full Text] [Related]
19. Systemic Activation of NRF2 Alleviates Lethal Autoimmune Inflammation in Scurfy Mice.
Suzuki T; Murakami S; Biswal SS; Sakaguchi S; Harigae H; Yamamoto M; Motohashi H
Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28507037
[TBL] [Abstract][Full Text] [Related]
20. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
